New tool may help identify newborns at highest risk for deve

On the heels of a shortage of nirsevimab for infant respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) prevention, a new tool may help identify newborns at highest risk for developing serious RSV LRTI, according to research published at the ATS 2024 International Conference.

Related Keywords

Netherlands , United States , Vanderbilt University , Tennessee , American , Tebeb Gebretsadik , Tinav Hartert , Niek Achten , Brittneym Snyder , Centers For Disease Control Prevention , Vanderbilt University Medical Center , Department Of Biostatistics , Erasmus University Medical Center , International Conference , American Thoracic Society , Tennessee Medicaid Program , Division Of Allergy , Critical Care Medicine , Vanderbilt University Medical , Disease Control , Principal Investigator Tina ,